Alkermes
Price & Volume
Stats
See more52W Range | $27-$55.67 |
Market Cap | $6.8B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $1.6B |
Revenue Growth (YoY) | 27% |
Gross Profit (12 Mos) | $1.4B |
Diluted EPS | $0.38 |
News
See moreYahoo Finance • 18 days ago
Why Alkermes (ALKS) Is Down 6.0% After First ADHD Data For Orexin Agonist ALKS 7290
Yahoo Finance • 19 days ago
Alkermes Posts Positive Data From Phase I ADHD Study on ALKS 7290
Yahoo Finance • 20 days ago
Alkermes rises on phase 1 results for ADHD drug ALKS 7290
Yahoo Finance • 25 days ago
Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors
About
CEO | Mr. Blair C. Jackson |
CFO | Mr. Joshua Reed M.B.A. |
Address | Connaught House, Dublin, Ireland, D04 C5Y6 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 2,050 |